HIMSHims & Hers Health Inc
Mkt Cap
$10.03BVolume
44.01M52W High
$72.9852W Low
$19.15PE Ratio
55.56HIMS Fundamentals
Price
$44.37Prev Close
$44.39Open
$45.7450D MA
$51.41Beta
2.03Avg. Volume
28.29MEPS (Annual)
$0.5322P/B
17.81Rev/Employee
$901,963.35OMCL vs. HIMS: Which Stock Is the Better Value Option?
OMCL vs. HIMS: Which Stock Is the Better Value Option?
Zacks·2h ago
Hims & Hers Health, Inc. (HIMS) Q3 Earnings Match Estimates
Hims & Hers Health (HIMS) delivered earnings and revenue surprises of 0.00% and +2.62%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·20h ago
Hims & Hers Health, Inc. Reports Third Quarter 2025 Financial Results
Hims & Hers Health, Inc. (Hims & Hers or the Company, NYSE: HIMS), the leading health and wellness platform, today announced financial results for the third quarter ended September 30, 2025, in a...
Business Wire·22h ago
OMCL vs. HIMS: Which Stock Should Value Investors Buy Now?
OMCL vs. HIMS: Which Stock Is the Better Value Option?
Zacks·1d ago
Hims & Hers Scales AI-Driven Personalized Health and Wellness
HIMS scales AI-driven care with new hormonal health lines, global expansion plans and a $870 million funding boost.
Zacks·4d ago
LEVI & KORSINSKY ISSUES CORRECTION: Securities Fraud Class Action Against Hims & Hers Health, Inc.
LEVI & KORSINSKY ISSUES CORRECTION: Securities Fraud Class Action Against Hims & Hers Health, Inc. LEVI & KORSINSKY ISSUES CORRECTION: Securities Fraud Class Action Against Hims & Hers Health, Inc...
PR Newswire·6d ago
Can Sustained Product Demand Drive HIMS Stock Before Q3 Earnings?
Hims & Hers benefits from strong platform engagement and hormonal health launches ahead of third-quarter 2025 earnings.
Zacks·6d ago
Analysts Estimate Nyxoah SA (NYXH) to Report a Decline in Earnings: What to Look Out for
Nyxoah (NYXH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·6d ago